Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study

BACKGROUND: Fibroblast growth factor 23 (FGF23) is emerging as a novel biomarker of bone metabolism, chronic kidney disease, and cardiovascular disease (CVD). However, its clinical correlates and potential predictive role in a community‐based setting are incompletely understood. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Haring, Robin, Enserro, Danielle, Xanthakis, Vanessa, Mitchell, Gary F., Benjamin, Emelia J., Hamburg, Naomi M., Sullivan, Lisa, Nauck, Matthias, Wallaschofski, Henri, Vasan, Ramachandran S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015386/
https://www.ncbi.nlm.nih.gov/pubmed/27385427
http://dx.doi.org/10.1161/JAHA.116.003486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015386/
https://www.ncbi.nlm.nih.gov/pubmed/27385427
http://dx.doi.org/10.1161/JAHA.116.003486

Ejemplares similares